Clinical trial
Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced…
NCT00259675 · University of Saskatchewan, Other · Completed
Key facts
| NCT number | NCT00259675 |
|---|---|
| Title | Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC |
| Official title | Treatment of Stages IIIB and IV, Non Small Cell Lung Cancer With Alternating Cycles of Carboplatin/Taxol and Carboplatin/Gemcitabine. |
| Lead sponsor | University of Saskatchewan, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin/gemcitabine, carboplatin/taxol |
| Enrollment | 100 |
| Start date | May 1, 2004 |
| Completion | May 1, 2007 |
| First posted | Nov 29, 2005 |
| Last update posted | Nov 15, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: